The wording is misleading and implies conclusive results.
I have no objection to any notion of electromagnetic fields, heck, MRI's are large magnets and they produce imaging that would have sounded nutty 30 years ago. Yet they work, with a ton of sophisticated technology and software and testing behind it, and it is proven.
It's not magnets per se, it's the specious claims: "beat depression" ( serious disease that affects about 1 in 4 Americans).
And that Dr. George ( an appeal to authority) say "that it works by..."
>>
Help beat depression with a MAGNET. US expert Dr Mark George says the therapy works by jump-starting a mood-regulating part of the frontal brain with high-powered magnets.<<
Now, a quick sniff of the internet reveals that you have made a good point, but, not the point made in the article I cited. I still don't know if magnets "beat depression" however, I do know that the work is: an investigational procedure.
Where's the potential good?
If people can avoid costly meds, or ECT, excellent!
Where's the potential harm in portraying it as a "treatment that works?"
Well, it's just not true. It's under investigation.
If people delay proper treatment.
If people spend hard earned money in some charlatan practice out there that abuses this type of treatment, and does not follow protocol.
The protocol, at least Emory, is:
"Who should get TMS?
Usually, TMS is considered after a person has tried one or more antidepressant medication trials and still has significant depressive symptoms. It can also be used for those patients who cannot tolerate antidepressant medications because of the side effects."
Or, as you alluded to, if this preliminary work, which is ripe for abuse, get's into the hands of someone who literally charges for treatment with refrigerator magnets. :eyes:
There are many shoe insert magnets out there for foot pain. Hats with magnets are a worry. The science behind magnets is what is of interest. Not magnets per se.
Magnets are not so much the issue as the claim that the treatment is now proven, because it is, at this stage, investigational. At least according to Emory University, "Both the treatment and the machine used to deliver the treatment are experimental."
BTW- the article I cited actually showed a common house magnet and not some sophisticated device at Emory.
http://www.emoryhealthcare.org/departments/fuqua/patient_info/TMS.html>>What is transcranial magnetic stimulation?
Transcranial magnetic stimulation is an investigational procedure used to treat major depression. The technique involves use of an electromagnetic coil to create electromagnetic pulses in the brain which have an antidepressant effect. Both the treatment and the machine used to deliver the treatment are experimental. The fact that they are experimental means that the Food and Drug Administration (FDA) has not yet approved TMS as a treatment for major depression. TMS is, however, approved for other medical uses. Studies involving TMS are being done to evaluate its safety and effectiveness as a treatment for depression.
How is TMS administered?
TMS is offered in the United States both in private practice and through research studies. While most studies are free or of low cost, treatment in private practice can be more expensive and will not be covered by insurance. The treatment is typically administered five times per week at the same time of day for up to six weeks. The patient is awake and alert during the treatment; there is no anesthesia involved.<<
If the article had simply stated, Investigation is under way to determine the "efficacy of of an electromagnetic coil to create electromagnetic pulses in the brain which may have an antidepressant effect,"
it would have been more accurate.
Here's a current article from a quick search. BTW- I do hope it proves to be a useful treatment. Thank you for bringing this up for discussion. It is always worth it to see what is cooking in R&D. :)
Curr Opin Psychiatry. 2009 May;22(3):306-11.
Transcranial direct current stimulation as a therapeutic tool for the treatment of major depression: insights from past and recent clinical studies.Murphy DN, Boggio P, Fregni F.
Berenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
PURPOSE OF REVIEW: Transcranial direct current stimulation (tDCS) is a noninvasive method of brain stimulation that has been increasingly tested for the treatment of neuropsychiatric disorders. It has useful characteristics, such as low cost, ease of use, reliable sham methodology, and relatively powerful effects on cortical excitability. Because of its potential to modulate cortical excitability noninvasively, tDCS has been tested for the treatment of depression for several decades. Therefore, we reviewed evidence on the use of tDCS for major depression examining evidence from past and recent tDCS studies. We also briefly compared tDCS with other techniques of neuromodulation, namely deep brain stimulation, vagal nerve stimulation, and transcranial magnetic stimulation; and suggest future directions for the use of tDCS in major depression. RECENT FINDINGS: Results from past clinical trials testing direct current stimulation as a therapeutic tool had mixed methodology and showed heterogeneous results. Recent studies on tDCS and depression using novel approaches, such as different parameters of stimulation, have improved its neuromodulatory effect thus resulting in larger clinical effects. In fact, two recent small trials have shown that tDCS is associated with significant clinical gains. SUMMARY:
On the basis of these findings there is still not enough evidence to support tDCS as a therapeutic modality for depression. However, findings to date encourage further studies in this area that should explore novel parameters of stimulation. In fact, it appears that current methods of tDCS might not be fully optimized and, in fact, (1) individualized parameters of stimulation, (2) longer stimulation sessions, and (3) methods to focalize tDCS might be useful strategies to provide greater clinical benefits.